aod9604 vs retatrutide 🧬 & AOD9604: A Deep Dive into the "Triple-Plus" Protocol We know that Retatrutide is the new heavy-hitter on the block, but when you add to the mix, you aren't AOD 9604 and retatrutide: evidence,

The FDA has escalated enforcement against compounded GLP-1 marketing since September 2025, Novo Nordisk launched the first FDA-approved oral semaglutide pill in January 2026, and compounding pharmacy supply chains are narrowing as regulatory pressure increases

Think Thanksgiving dinner, but without all the carbs and your aunt asking why you haven't had kids yet

The Wegovy pill costs $149 a month for a 1.5 mg dose, but can go as low as $25 per month if covered by insurance

A disruption to this fine-tuned physiological process, where net energy consumption outweighs that of energy utilization, can lead to metabolic dysfunction

Our full guide to Medicare Advantage Plans in Washington State walks through how to evaluate these tradeoffs county by county